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Intermittent fasting (IF) was suggested to be a powerful nutritional strategy to prevent the
onset of age-related neurodegenerative diseases associated with compromised brain
bioenergetics. Whether the application of IF in combination with a mitochondrial insult
could buffer the neurodegenerative process has never been explored yet. Herein, we
defined the effects of IF in C57BL/6J mice treated once per 24 h with rotenone (Rot)
for 28 days. Rot is a neurotoxin that inhibits the mitochondrial complex I and causes
dopamine neurons degeneration, thus reproducing the neurodegenerative process
observed in Parkinson’s disease (PD). IF (24 h alternate-day fasting) was applied alone
or in concomitance with Rot treatment (Rot/IF). IF and Rot/IF groups showed the same
degree of weight loss when compared to control and Rot groups. An accelerating
rotarod test revealed that only Rot/IF mice have a decreased ability to sustain the test at
the higher speeds. Rot/IF group showed a more marked decrease of dopaminergic
neurons and increase in alpha-synuclein (α-syn) accumulation with respect to Rot
group in the substantia nigra (SN). Through lipidomics and metabolomics analyses,
we found that in the SN of Rot/IF mice a significant elevation of excitatory amino
acids, inflammatory lysophospholipids and sphingolipids occurred. Collectively, our data
suggest that, when applied in combination with neurotoxin exposure, IF does not
exert neuroprotective effects but rather exacerbate neuronal death by increasing the
levels of excitatory amino acids and inflammatory lipids in association with altered brain
membrane composition.
Keywords: mitochondria, lysophospholipids, excitatory amino acids, Parkinson’s disease
Abbreviations: α-syn, alpha-synuclein; ALT, alanine transaminase; CPK, creatine phospho-kinase; GOT, glutamic
oxaloacetic transaminase; IGF-1, Insulin-like growth factor 1; IF, intermittent fasting; LPA, lysophosphatidic acid;
LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
NMDA, N-methyl-D-aspartate ionotropic glutamate receptor; PD, Parkinson’s disease; Rot, rotenone; SN, substantia nigra;
TH, tyrosine hydroxylase.
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INTRODUCTION
Advanced age is the major risk factor for metabolic and
neurodegenerative disorders (Zierer et al., 2015). Mounting
evidence from clinical studies and basic research indicate
that metabolic dysfunction and brain function decline are
causally linked. Type 2 diabetes mellitus appears to be a severe
risk factor for developing dementia and neuromotor disease
including Parkinson’s disease (PD; Athauda and Foltynie, 2016).
Interestingly, insulin resistance in PD patients is associated
with a more severe progression of the disease (Athauda and
Foltynie, 2016) and insulin resistance has been proposed to
be a good predictor of cognitive decline in humans (Ekblad
et al., 2017). In experimental models, such phenomenon seems
to be caused by increased dopaminergic neuron degeneration.
Actually, fat overload in murine models of PD exacerbates
neurodegeneration by stimulating iron deposition and specific
basal ganglia changes in substantia nigra (SN) leading to
impaired nigrostriatal dopamine function (Morris et al., 2011;
Rotermund et al., 2014).
All these findings lead researchers to study whether reducing
calorie intake by caloric restriction or fasting-based dietary
strategies could prevent neurodegeneration. The molecular
events activated by fasting are conserved from yeast to human
and share the ability to protect brain function and metabolic
health (Lettieri Barbato et al., 2012, 2015; Lettieri Barbato and
Aquilano, 2016). Intermittent fasting (IF) is a generic term used
to describe different forms of fasting such as alternate day fasting,
periodic fasting, time-controlled fasting. Experimental evidence
demonstrates a preventive role of IF in cognitive decline and
many neurodegenerative disorders including PD both in rodents
and human (Anton and Leeuwenburgh, 2013; Wahl et al., 2016;
Mattson et al., 2017).
Omics approaches are an emerging field to evaluate
the metabolic changes occurring after treatments or
pathophysiological conditions. Lipids are a vast and
heterogeneous class of compounds playing a plethora of
functions in the brain including myelin formation (Schmitt
et al., 2015), signaling (Michel and Bakovic, 2007), inflammation
and neuroprotection (Orr et al., 2013) and are strongly
related to neurological diseases (Lauwers et al., 2016). Food
restriction was effective in preventing phospholipid turnover
dysfunction in the brain during aging (Babenko and Shakhova,
2014). Shotgun lipidomics showed that caloric restriction
determines important changes in myelin composition in the
brain (Kiebish et al., 2012). Specific nutrient restrictions such
as methionine restriction have important effects on brain lipid
compositions. It has been observed that methionine-restricted
mice undergo phospholipid changes and become more resistant
to oxidative stress (Jové et al., 2013). This highlights a potential
mechanism by which restriction of nutrients may improve
brain functionality by phospholipids remodeling. Peculiar
increases of brain amino acids, particularly those involved in
neurotransmission, define several brain dysfunctions (Sheldon
and Robinson, 2007). Notably, fasting strongly impacts on
amino acid profile promoting significant reductions in plasma
and tissues.
Environmental chemicals represent risk factors for
neurodegenerative diseases including PD (Cannon and
Greenamyre, 2011). The majority of PD cases are sporadic
and chronic exposure to pesticides, such as the complex
I inhibitors rotenone (Rot), may play a major role in the
pathogenesis (Ascherio and Schwarzschild, 2016). Whether IF
may be protective also in this paradigm is currently undefined.
Herein, we characterized the effect of IF in modulating
brain metabolism and dopaminergic neuron degeneration
by using metabolomics approaches. In particular, we treated
mice with Rot in combination with IF. Rot is able to induce
selective degeneration of dopaminergic neurons and PD-like
features in animals (Inden et al., 2011; Tanner et al., 2011).
We found that 1 month IF was not sufficient to induce
metabolic changes in SN; however, IF exacerbated Rot-mediated
dopaminergic degeneration that was associated with increased
inflammatory phospholipids and excitatory amino acids
levels.
MATERIALS AND METHODS
Mice and Treatments
We conducted all mouse experimentations in accordance
with accepted standard of humane animal care and with the
approval by relevant local (Institutional Animal Care and Use
Committee, University of Rome Tor Vergata) and national
(Ministry of Welfare, licence no. 331/2016-PR) committees.
Experiments were carried out according to institutional safety
procedures. Thirty-two C57BL/6J adult (8 weeks-age-old) male
mice (purchased from Harlan Laboratories S.r.l., Urbino, Italy)
were randomly divided in four groups: control mice (Ctr),
IF-treated mice, Rot-treated mice (Rot) and IF/Rot-treated
mice (IF/Rot). Rot (30 mg/Kg/day; R8875 Sigma-Aldrich) was
dissolved in water supplemented with 4% sodium carboxymethyl
cellulose (419273 Sigma-Aldrich) and 3% chloroform and daily
dispensed via gavage for 28 days (Inden et al., 2011). The
same solution without rotenone was administered to Ctr and
IF mice groups. IF treatment was carried out alternating 24 h
ad libitum food intake with 24 h fasting for 28 days. Rot
treatment was started at the first day of fasting and, at the end
of treatment, IF and IF/Rot groups were in the fasting state. The
Ctr and Rot groups were starved for 2 h, and blood collected
to perform bioclinical analyses by colorimetric methods. In
particular, glucose, cholesterol, triglycerides, creatinine, creatine
phospho-kinase (CPK), alanine transaminase (ALT), glutamic
oxaloacetic transaminase (GOT) were measured through the
automatized KeyLab analyzer (BPCBioSed, Italy) using specific
assay kits (BPCBioSed). Sera Insulin-like growth factor 1 (IGF-1)
levels were detected by using Mouse IGF-1 Elisa Kit (Abcam)
according to the manufacturer’s instructions. Before sacrifice all
mice groups were weighted. After cervical dislocation brain, liver
and heart were explanted and weighted. Brains were immediately
processed or stored at−80◦C.
Rotarod
Rotarod analyses were performed to test mice latency to fall in
order to evaluate the effects on motor coordination. Rotarod
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analyses were performed both at the baseline prior the first
rotenone administration (not included in the results) and 2 days
before the end of treatment (at the fasting day and prior rotenone
administration). Mice were placed on the rotarod (for mice,
Cat N◦ 47600, Ugo Basile s.r.l., Italy) and sequentially tested at
different speeds from 7 rpm to 25 rpm. When mice felt of the
rotarod, they were placed back on it for the remaining time. On
testing days, each mouse performed one pre-trial (not included
in the results) to enable the mice to habituate to the rotarod. The
trial was carried out after 2 h of rest.
Immunohistochemistry
Intact brains were removed and immerged in Carnoy’s fixing
solution (60% ethanol, 30% chloroform and 10% glacial acetic
acid) overnight at 4◦C. Brains were dehydrated with three washes
in EtOH absolute, cleared with three washes of Histoclear and
embedded in paraffin. Dopaminergic region was identified
starting at approximately Bregma −4.30 mm to Bregma
−2.63 mm according to Allen Mouse Brain Atlas. This area
was cut in 25 µm cross sections with a Leitx rotary microtome.
Seventy sections were placed on 13 slides in order to have
complete posterior-anterior series and consecutive slides with
adjacent sections. Slides were stained with tyrosine-hydroxylase
(TH) polyclonal antibody (diluted 1:100, sc-14007 Santa-Cruz
Biotechnologies) or alpha-synuclein (α-syn) monoclonal
antibody (diluted 1:100, ab138501 Abcam). HRP-conjugated
secondary antibodies (1:300 Bio-Rad) and aminoethylcarbazone
(AEC Kit, Sigma-Aldrich) as HRP chromogenic substrate were
then used.
TH-positive neurons and TH-positive areas were obtained
by using ImageJ (Schneider et al., 2012); the sum of each
area was multiplied by slides thickness (25 µm) to obtain the
volume of SN. α-syn immunostaining was optically quantified
for each slide by using ImageJ software according to Mulcahy
et al. (2012). Briefly, mean gray values of stained and
unstained (background) regions were calculated and converted
to optical densities by applying the conversion formula in
ImageJ (optical density = log10(255/mean gray value). Final
optical densities were calculated as the difference in staining
between stained and unstained regions. To ensure accuracy of
the data, immunohistochemical procedures were simultaneously
performed on each sample and all images captured by using
Axiolab A1 Zeiss microscope connected to a digital camera
(Axiocam ICC5) in the same conditions of bright field
illumination and time of exposure.
Metabolomics
SN were resuspended and lysed in MeOH/ACN 1:1 and spun at
20,000 g for 5 min at 4◦C. Supernatant was saved for subsequent
analysis. Amino acids quantification was performed by previous
derivatization. Briefly, 50 µl of 5% phenyl isothiocyanate (PITC)
in 31.5% EtOH and 31.5% pyridine in water were added to 10 µl
of each sample. Mixtures were then incubated with PITC solution
for 20 min at RT, dried under N2 flow and suspended in 100 µl
of 5 mM ammonium acetate in MeOH/H2O 1:1.
Metabolomic data were performed on an API-4000 triple
quadrupole mass spectrometer (AB SCIEX) coupled with a
HPLC system (Agilent) and CTC-PAL-HTS auto sampler (PAL
System). The identity of all metabolites was confirmed using
pure standards. Quantification of different amino acids was
performed by using a C18 column (Biocrates). Methanolic
samples were analyzed by a 10-min run in positive ion mode
with a 20 multiple reaction monitoring (MRM) transition. The
mobile phases for positive ion mode analysis (amino acids)
were phase A: 0.2% formic acid in water and phase B: 0.2%
formic acid in acetonitrile. The gradient was T0 100% A, T5
5 min 5% A, T7 min 100% A with a flow rate of 500 µl/min.
MultiQuantTM software (version 3.0.2) was used for data analysis
and peak review of chromatograms. Quantitative evaluation
of all metabolites was performed based on calibration curves
with pure standards, and then data were normalized on protein
content.
Phospholipid Profile by Flow Injection
Analysis-Tandem Mass Spectrometry
(FIA-MS/MS)
Quantification of total fatty acids was performed as previously
described (Cermenati et al., 2017). Briefly, different phospholipid
family quantification was performed by flow injection analysis-
tandem mass spectrometry (FIA-MS/MS) method. The identity
of the different phospholipid families was confirmed using pure
standards, namely one for each family. Methanolic extracts
were analyzed by a 3-min run in both positive and negative
ion mode with a 268 MRM transition in positive mode
and 88 MRM transition in negative mode. An ESI source
connected with an API 4000 triple quadrupole instrument (AB
Sciex, Framingham, MA, USA) was used. The mobile phase
was 0.1% formic acid in MeOH for FIA positive analysis
and 5 mM ammonium acetate pH 7 in MeOH for FIA
negative. MultiQuantTM software version 3.0.2 was used for data
analysis and peak review of chromatograms. Semiquantitative
evaluation of PL families was performed based on external
standards.
Statistical Analysis
Statistical significance of the differences between group sample
mean values were determined by analysis of variance (ANOVA)
followed by the Student-Newman-Keuls test for pairwise
comparison of means. All statistical analyses were carried out
by using GraphPad Prism 5 Software (GraphPad Software). The
results are presented as mean± SD. Differences were considered
to be significant at p< 0.05.
RESULTS
To reproduce brain mitochondrial dysfunction, we treated mice
once per 24 h with Rot for 28 days according to Inden et al.
(2011). Treatment with the pesticide Rot in rodents inhibits
mitochondrial complex I and induces striatal degeneration thus
reproducing features of age-related neurological disorders such
as PD and parkinsonisms (Costa et al., 2008). Furthermore, the
Rot-treated mouse has been suggested to provide an interesting
animal model for preclinical examinations of neuroprotective
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FIGURE 1 | Intermittent fasting (IF) causes motor dysfunction in rotenone-treated mice. (A) Body weight was recorded immediately before and at the end of
treatment. Data are expressed as means ± SD (n = 4; F(7,8) = 5.60; ∗p < 0.05 vs. Ctr). (B) A rotarod test was performed at different times and speeds to evaluate
motor function (n = 4, F(3,12) = 4.01; ∗p < 0.05 vs. Ctr).
strategies (Inden et al., 2011). To evaluate the effects of IF, we
compared Rot-treated (Rot) mice with a group of Rot-treated
mice subjected to IF (Rot/IF). In line with other studies, Rot
did not cause changes in body weight (Inden et al., 2011; Liu
et al., 2015), whereas IF caused about 10% decrease of body
weight that was comparable to that observed in Rot/IF-treated
mice (Figure 1A). These findings are in line with previous works
revealing the slimming effect of IF (Lettieri-Barbato et al., 2016).
No alterations in brain weights and other organs, such as liver
and heart, were instead observed (data not shown). Bioclinical
analyses reported in Table 1 revealed that all groups did not
manifest metabolic alterations as assessed by analyzing fasting
glycaemia, blood cholesterol and triglycerides. Also, the analysis
of blood creatinine, CPK, ALT, GOT indicated that kidney,
skeletal muscle and liver damage were not induced. The analysis
of serum IGF-1 levels showed that they were decreased both in IF
and Rot/IF groups with respect to Ctr and Rot groups (Table 1).
This result confirmed the effectiveness of IF, as lowered IGF-1
levels are found upon different dietary restriction regimens in
rodents and human (Mitchell et al., 2010; Lettieri-Barbato et al.,
2016).
To assess the possible acquisition of motor dysfunction, we
carried out an accelerating rotarod test. As reported in Figure 1B,
IF did not lead to alteration in the motor function, while a
significant decrease in the mouse ability to sustain the test
was observed in Rot and Rot/IF group. However, the Rot/IF
mice started to manifest the motor dysfunction at minor speeds
(20 rpm, 30 s) with respect to Rot group (30 rpm, 30 s) as showed
in Figure 1B.
To validate the occurrence of anatomical lesions in
dopaminergic area we next performed an immunohistochemistry
analysis of TH-positive neurons. Rot treatment induced
significant changes in the SN. Actually, we observed a
decrease in the number of TH-positive neurons (Figures 2A,B)
accompanied by a reduction in overall SN volume (Figure 2C)
with respect to controls. Notably, this tissue damage was higher
in Rot/IF with respect to Rot-treated mice (Figures 2A–C).
Differently, IF did not induce changes in the number of
TH-positive neurons and SN volume (Figures 2A–C). We
also performed an immunohistochemistry determination of
α-syn. According to the data obtained analyzing TH-positive
neurons, we found that α-syn accumulation was well detectable
in Rot-treated group and its immunoreactive levels were
further increased when Rot was used in combination with IF
(Figures 2A,D).
Amino acids are important players in neurotransmission
and take center place in excitatory pathways (Shaw, 1992).
Altered levels of excitatory amino acids characterize several
neurodegenerative disorders including PD (Salin´ska et al., 2005;
Blandini, 2010). Thus, we measured the levels of all the amino
acids in the SN-enriched region of the brain. Among the
detectable amino acids, we found increased levels of glutamate,
glutamine, aspartate, glycine only in Rot/IF group, whereas no
amino acids variations were observed in other groups (Figure 3).
TABLE 1 | Clinical biochemistry parameters and serum insulin-like growth factor 1 (IGF-1) levels.
Ctr IF Rot Rot/IF
Glucose (mg/dl) 60–120 82.00 ± 13.49 78.83 ± 16.67 80.83 ± 19.34 87.0 ± 10.95
Creatinine (mg/dl) 0.50–1.20 0.82 ± 0.08 0.86 ± 0.22 0.78 ± 0.05 0.92 ± 0.18
Cholesterol (mg/dl) 50–120 71.00 ± 17.37 84.0 ± 20.71 77.66 ± 7.71 82.6 ± 12.52
Triglycerides (mg/dl) 80–200 85.33 ± 6.05 83.83 ± 2.14 88.17 ± 6.94 85.2 ± 3.35
AST (U/L) 20–250 54.17 ± 13.65 80.00 ± 40.48 49.00 ± 8.15 40.8 ± 16.51
Alanine transaminase (ALT) (U/L) 20–100 26.38 ± 4.48 24.48 ± 1.70 26.60 ± 4.06 26.54 ± 5.65
Creatine phospho-kinase (CPK) (U/L) 100–300 219.50 ± 61.08 162.00 ± 67.05 254.17 ± 67.62 234.4 ± 60.57
IGF-1 (pg/ml) 1005 ± 40 866 ± 30∗ 1100 ± 118 901 ± 32#
Mice were treated daily with rotenone (Rot) concomitant to normal feeding with control diet or intermittent fasting (IF, 24 h alternate-day fasting) for 28 days. Prior sacrifice,
mice were starved for 2 h and blood was collected for clinical biochemistry analyses and for assessing IGF-1 levels (n = 6 each group, ∗p = 0.013, #p = 0.034 vs. Ctr).
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FIGURE 2 | IF enhances neurodegeneration caused by rotenone treatment. (A) Brains were fixed and used for immunohistochemistry analysis of dopaminergic
neurons and α-synuclein (α-syn) by staining through tyrosine hydroxylase (TH) and synuclein antibody, respectively. Images reported are from one mice of each group
and representative of four giving similar results. (B) Total TH positive (TH+) neurons in the slices including substantia nigra (SN) were counted for each group by using
ImageJ software (F(3,12) = 220.20; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. Ctr; #p < 0.01 vs. Rot). (C) SN volume was calculated for each group by using ImageJ software
(F(3,4) = 20.44; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. Ctr; #p < 0.01 vs. Rot). (D) α-syn immunoreactivity was quantified for each group by using ImageJ software and
expressed as optical density (F(3,28) = 7.16; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. Ctr; #p < 0.01 vs. Rot). Data are expressed as means ± SD (n = 4 each group).
Brain phospholipid composition could be significantly altered
as consequence of neuronal loss and inflammatory processes
(Farooqui et al., 2004). Thus, we analyzed phospholipid
composition of SN-enriched brain regions. The obtained
lipidomic profile identified 218 phospholipids. Among these,
10 were up-regulated in IF, about 74 in Rot, 152 in Rot/IF group.
Sixty-nine phospholipids were in common between Rot and
Rot/IF group and 60 were up-regulated exclusively in the Rot/IF
group. Regarding Rot/IF group, the up-regulated phospholipids
belonged to all the species but not sulfatide (data not shown)
and the most affected classes (with 100% of the detected species
increased) were sphingomyelin (SM) and the lysophospholipids
i.e., lysophosphatidic acid (LPA), lysophosphatidylcholine
(LPC) and lysophosphatidylethanolamine (LPE; Supplementary
Figure S1 and Figure 4).
DISCUSSION
In this work, we reproduced PD-like features through Rot
treatment in mice and demonstrated that the concomitant
administration of IF imposes significant metabolic alterations
in SN-enriched regions that are associated with the
aggravation of dopamine neuron degeneration as well as
motor dysfunction.
Our results are in contrast with many others showing that
dietary restriction exerts a neuroprotective function. In these
studies, dietary restriction was applied for very long periods
prior to a neurotoxic insult allowing the activation of neuronal
stress responses that could mitigate the neurodegenerative
processes. In particular, IF was found to protect hippocampal
or dopaminergic neuron degeneration when applied prior
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FIGURE 3 | Exacerbation of rotenone-mediated dopaminergic degeneration is associated with increased excitatory amino acids levels in mice subjected to IF. Brain
region containing SN were analyzed by LC-MS/MS. Heat map reports amino acids levels for each group. Gly (F(3,8) = 6.77, ∗∗p < 0.01 Rot + IF vs. Ctr), Ser
(F(3,8) = 5.33, ∗p < 0.05 Rot + IF vs. Ctr), Asn (F(3,8) = 4.59, ∗∗p < 0.01 Rot + IF vs. Ctr), Asp (F(3,8) = 7.37, ∗∗p < 0.01 Rot + IF vs. Ctr), Gln (F(3,8) = 10.31,
∗∗p < 0.01 Rot + IF vs. Ctr), Glu (F(3,8) = 18.88, ∗∗p < 0.01 Rot + IF vs. Ctr), Lys (F(3,8) = 5.81, ∗p < 0.05 Rot + IF vs. Ctr). Data are expressed as means ± SD
(n = 3 for Rot + IF group; n = 4 for the other groups).
excitotoxic insults or mitochondrial toxin 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) treatment in rodents (Bruce-
Keller et al., 1999; Duan and Mattson, 1999). Pre-treatment
with dietary restriction was also found to protect dopaminergic
neurons in a murine PD model using lactacystin (Coppens et al.,
2017). Attenuated motor deficits were observed in monkeys
that were fed with 30% of calorie reduction for 6 months
prior to treatment with MPTP (Maswood et al., 2004). The
protective effects of dietary restriction have been ascribed
to its ability to lower mitochondrial reactive oxygen species
production and raise antioxidant levels (Walsh et al., 2014) or
to enhance the production of neurotrophic factors (i.e., glial
cell line-derived neurotrophic factor, brain-derived neurotrophic
factor) with consequent activation of neuroprotective signal
transduction pathways in domaminergic neurons (Maswood
et al., 2004).
A study from the group of Armentero et al. (2008) showed
that dietary restriction was instead not able to prevent the
degeneration of dopaminergic neurons in rodents treated with
the PD toxin 6-hydroxydopamine. These authors suggested that
the lack of protection was due to the too short period of dietary
restriction regimen preceding 6-hydroxydopamine treatment
that did not allow the development of stress resistance signaling
pathways.
To the best of our knowledge, our work represents the
first study investigating the effect of IF concomitant to an
environmental insult and demonstrating a deleterious effect of
IF. We show that even though IF lowers body weight and IGF-1
plasma levels, IF alone did not produce significant alterations
in SN. Intriguingly, when administered in combination with
Rot treatment, IF leads to significant increase of excitatory
amino acids as well as phospholipids levels in SN and
exacerbates dopamine neurons degeneration, arguing that IF was
likely unable to activate neuroprotective response against Rot
toxicity.
The loss of dopamine due to the degeneration of the neurons
in the SN elicits alterations of the neurotransmitter circuitry
in the basal ganglia (Calabresi et al., 2007; Obeso et al., 2008)
and, as consequence, an imbalance of neurotransmission may
develop in the nigrostriatal system (Cobb and Abercrombie,
2003; Bradner et al., 2013). Amino acids play an important
role in the metabolism of neurotransmitters. When present
at high levels in the brain they can be toxic to neurons, a
phenomenon known as ‘‘excitotoxicity’’. N-methyl-D-aspartate
ionotropic glutamate receptor (NMDA) is a ligand-gated
ion channel that is crucial for excitatory neurotransmission
and its excessive activation plays a key role in mediating
some aspects of synaptic dysfunction in several neuronal
disorders including PD (Lau and Tymianski, 2010). Increased
excitatory neurotransmitters have been found in plasma and
brain of PD patients and mice models (Iwasaki et al., 1992;
Assous et al., 2014). Glutamate is the predominant excitatory
neurotransmitter in the central nervous system (Meldrum,
2000). Glutamine represents a precursor of the excitatory
transmitter glutamate and aspartate (Holten and Gundersen,
2008). Glycine exerts excitatory effects in the cortex as well
as hippocampal neurons by acting as a NMDA receptor
co-agonist increasing the affinity of NMDA receptors for
glutamate (Fadda et al., 1988; Barth et al., 2005). With all this
in mind, it is conceivable that the exacerbation of Rot-mediated
neurodegeneration triggered by IF could at least in part
depend on the increase of excitatory amino acids that we
observed in SN.
Changes in the lipidome profile could occur in regions
undergoing significant neuronal loss and inflammation. Actually,
a number of phospholipids are involved in inflammatory
cascades, and maintenance of phospholipids homeostasis
is fundamental for assuring physiological function of cell
membrane of brains cells (Posse de Chaves and Sipione,
2010; Aureli et al., 2015). In addition to the degeneration of
dopaminergic system, gliosis is a prominent feature of PD
(Członkowska and Kurkowska-Jastrze˛bska, 2011) that can
be observed also in PD animal models (Strömberg et al.,
1986). Our data suggest that IF worsens the harmful effects
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FIGURE 4 | Levels of inflammatory lysophospholipids and sphingomyelin (SM) are increased in mice treated with rotenone and subjected to IF. Brain regions
containing SN were analyzed by LC-MS/MS. Levels of LPC coline species 20:4 (F(3,11) = 10.54; ∗∗p < 0.01 vs. Ctr), LPC 18:0 (F(3,11) = 11.52; ∗∗p < 0.01 vs. Ctr),
LPC 18:1 (F(3,12) = 103.61; ∗∗∗p < 0.001 vs. Ctr), LPC 16:0 (F(3,12) = 13.72; ∗∗p < 0.01 vs. Ctr) and LPC 16:1 (F(4,12) = 23.72; ∗∗p < 0.01 vs. Ctr) (A);
lysophosphatidic acid (LPA) species LPA 16:0 (F(3,11) = 8.71; ∗∗∗p < 0.001 vs. Ctr), LPA 18:0 (F(3,11) = 4.38; ∗p < 0.05 vs. Ctr) and LPA 18:1 (F(3,11) = 7.88;
∗p < 0.05, ∗∗∗p < 0.001 vs. Ctr) (B); lysophosphatidyl ethanolamine (LPE) specie 20:4 (F(3,7) = 12.88; ∗∗∗p < 0.001 vs. Ctr) (C); lysophosphatidyl inositol (LPI)
species LPI 18:0 and LPI 18: 1 (F(3,11) = 10.63; ∗p < 0.05 vs. Ctr) (D); SM species SM 26:0 (F(3,11) = 5.78; ∗p < 0.05 vs. Ctr), SM 26:1 (F(3,11) = 4.97; ∗p < 0.05 vs.
Ctr), SM 24:0 (F(3,11) = 7.39; ∗∗p < 0.01 vs. Ctr), SM 24:1 (F(3,11) = 8.49; ∗∗p < 0.001 vs. Ctr), SM 22:3 (F(3,11) = 17.14; ∗p < 0.05, ∗∗p < 0.01 vs. Ctr), SM 20:2
(F(3,11) = 2.78; ∗p < 0.05 vs. Ctr), SM 18:0 (F(3,11) = 8.01; ∗∗p < 0.01 vs. Ctr), SM 18:1 (F(3,11) = 17.56; ∗∗p < 0.01 vs. Ctr), SM 16:0 (F(3,11) = 10.25; ∗∗p < 0.01 vs.
Ctr) and SM 16:1 (F(3,11) = 8.49; ∗∗p < 0.01 vs. Ctr) (E). Data expressed as means ± SD (n = 3 for Rot + IF group; n = 4 for the other groups).
of Rot by favoring lipid membrane disturbances and raising
the brain concentration of potentially inflammatory and
neurotoxic phospholipids. In support of this assumption,
elevated LPA and LPC were found to lead to brain injury
(Tigyi et al., 1995; Goldshmit et al., 2010) and are likely
involved in the pathogenesis of PD (Lee et al., 2005).
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Furthermore, it has been reported that elevated LPC levels
in the brain are potent attraction signals for phagocytes such
as activated microglia, astroglia and macrophages (Zhang
et al., 2007). The increased levels of SM could imply a
disruption of cell membranes, and in particular myelin
composition, and a pro-inflammatory state. Interestingly,
aberrant accumulation of sphingolipids in the prefontal cortex
may also contribute to dysregulation of synaptic vesicle fusion
and trafficking of NMDA receptors (Haughey et al., 2010), thus
explaining the detected imbalance of excitatory amino acid
profile.
The exact molecular mechanisms by which, in our model,
IF sensitizes dopaminergic neurons to the toxic effects of Rot
remain to be more deeply elucidated yet and are currently
under investigation in our laboratory. A hypothetical explanation
could be that upon fasting neurons have scarce levels of
nutrients and the concomitant inhibition of complex I by Rot
triggers a harmful energetic drop. It is now widely accepted
that excessive NMDA receptors stimulation aggravates PD via
the enhancement of mitochondrial damage (Greenamyre et al.,
1999). An increase of inflammatory lipids could also contribute
to damage mitochondria (Currais, 2015) and further create an
energetic drop that sensitizes neurons to Rot upon IF. Based
on this evidence, we can speculate that an increased death of
dopaminergic neurons could be operative in Rot/IF group and
at least in part due to an energetic crisis.
In conclusion, even though our results remain correlative, as
we have not tested the level of astrocytes and microglia markers
as well as dopaminergic neuron death, our work indicates that
IF should not to be always considered of safe application but
be followed with caution possibly only when external insults are
limited; indeed, it may produce important side-effects, such as
elevation of inflammatory lipids and excitatory amino acids levels
that could exacerbate dopaminergic neurons degeneration and
accelerate brain aging.
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